Same Indication

Lisinopril vs Tofacitinib

Lisinopril vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Lisinopril and Tofacitinib.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Lisinopril — 12 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5; Tofacitinib — C16H20N6O.

Molecular Weight: Lisinopril — 405.4900 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Lisinopril — Small molecule; Tofacitinib — Small molecule.